Targeted therapies and outcomes data: the inflammatory hypothesis matures.

dc.contributor.author	Sharan, Lauren
dc.contributor.author	Krasuski, Richard A
dc.coverage.spatial	England
dc.date.accessioned	2018-02-01T18:53:47Z
dc.date.available	2018-02-01T18:53:47Z
dc.date.issued	2018-02
dc.identifier	https://www.ncbi.nlm.nih.gov/pubmed/29298276
dc.identifier	00041433-201802000-00012
dc.identifier.eissn	1473-6535
dc.identifier.uri	https://hdl.handle.net/10161/16057
dc.language	eng
dc.publisher	Ovid Technologies (Wolters Kluwer Health)
dc.relation.ispartof	Curr Opin Lipidol
dc.relation.isversionof	10.1097/MOL.0000000000000477
dc.title	Targeted therapies and outcomes data: the inflammatory hypothesis matures.
dc.type	Journal article
duke.contributor.orcid	Krasuski, Richard A\|0000-0003-3150-5215
pubs.author-url	https://www.ncbi.nlm.nih.gov/pubmed/29298276
pubs.begin-page	56
pubs.end-page	57
pubs.issue	1
pubs.organisational-group	Clinical Science Departments
pubs.organisational-group	Duke
pubs.organisational-group	Medicine
pubs.organisational-group	Medicine, Cardiology
pubs.organisational-group	School of Medicine
pubs.publication-status	Published
pubs.volume	29

Files

Now showing 1 - 1 of 1